Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

Sunshine Lake Pharma prepares and tests MAP3K5 inhibitors

March 6, 2019

Sunshine Lake Pharma identifies new semicarbazide-sensitive amine oxidase inhibitors

Feb. 28, 2019

Generation of a novel nucleoside inhibitor for the treatment of ischemia-reperfusion injury

Feb. 28, 2019

Targeting DEFA1/DEFA3 ameliorates sepsis severity in mice

Feb. 27, 2019

Nicotinamide N-methyltransferase inhibitor enhances aged muscle regeneration

Feb. 27, 2019

Size matters for cell prowess

Feb. 15, 2019

Making jumping genes sit still could be antiaging strategy

Feb. 14, 2019

Rho-associated protein kinase 1/2 inhibitors disclosed by Kadmon

Feb. 12, 2019

PU.1 controls yin and yang of fibrosis

Feb. 6, 2019

U.S. Department of Health & Human Services patents fatty acid derivatives

Jan. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...